GeneDx Holdings Corp. provided revenue guidance for the fourth quarter and full year of 2023. For the quarter, company expects Continuing Operations revenues of at least $57 million and Total revenues of at least $58 million.

For the year, company expects Continuing Operations revenues of at least $193 million and Total revenues of at least $203 million.